Skip to main content

Introduction to In Vivo Platforms for Cancer Immunotherapy

Published Date

(recording date: 3/04/2021) Grace Berryhill, Ph.D. provides an overview of in vivo platforms being used to improve the translational relevance of cancer immunotherapies. Covered in this webinar are: * current approaches for cancer immunotherapy, * types of cancer immunotherapeutics that have been characterized and validated in mouse models, and * innovative humanized platforms for immuno-oncology drug development. A recorded Q&A session begins at 54:24:17.